Zobrazeno 1 - 10
of 49
pro vyhledávání: '"George, Makris"'
Autor:
George Makris
Publikováno v:
Wellcome Open Research, Vol 9 (2024)
Background The emergency context of the Covid-19 pandemic necessitated the use of national and international public health measures of unprecedented scale to minimize mortality and morbidity, often in conflict with other principles and rights, such a
Externí odkaz:
https://doaj.org/article/f40c269122bb4ddf85e12bfdab9706cd
Autor:
Victoria Giatraki, Helen Dimitriou, Aggelos Pappas, Dimitris Mamoulakis, George Makris, Emmanouil Galanakis, Chrysoula Perdikogianni
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 11, Pp 4291-4298 (2021)
Background Individuals with type 1 diabetes (T1D) are at increased risk of infections from vaccine-preventable diseases. This study focuses on compliance of T1D patients to the recommended vaccination schedule, vaccination of their close contacts for
Externí odkaz:
https://doaj.org/article/d46cae34574a4cf38757dc4a19f3e69c
Autor:
Stavroula DIMKOU, George MAKRIS
Publikováno v:
Buletin ştiinţific: Universitatea din Piteşti. Seria Ştiinţe Economice, Vol 16, Iss 1, Pp 60-73 (2017)
The reform and development of the financial sector was one of the most significant challenges that the former socialist countries faced during their transition to a market economy. At the start of this transition, their financial system was underdeve
Externí odkaz:
https://doaj.org/article/7253ad4c8f9748088a11e94e1eceae23
Autor:
George Makris, Eirini Tzanaki, Maria Bachlitzanaki, Eirini Pasparaki, Vasilis Amargianitakis, Androniki Naska, Vassiliki-Anastasia Sypsa, Dimitrios Paraskevis
Publikováno v:
Health & Research Journal; Τόμ. 9 Αρ. 2 (2023): Volume 9 Issue 2 April-June 2023; 79-95
Health & Research Journal; Vol. 9 No. 2 (2023): Volume 9 Issue 2 April-June 2023; 79-95
Health & Research Journal; Vol. 9 No. 2 (2023): Volume 9 Issue 2 April-June 2023; 79-95
Background: CoviD-19 in-hospital mortality rates show variations across time, setting, patient populations and health-systems. Aim: The aim of the present study was to explore the association of patient characteristics with in-hospital mortality taki
Autor:
Aggelos Pappas, George Makris, Dimitris Mamoulakis, Helen Dimitriou, Chrysoula Perdikogianni, Emmanouil Galanakis, Victoria Giatraki
Publikováno v:
Hum Vaccin Immunother
Background Individuals with type 1 diabetes (T1D) are at increased risk of infections from vaccine-preventable diseases. This study focuses on compliance of T1D patients to the recommended vaccination schedule, vaccination of their close contacts for
Autor:
Jing Wang, George Makris, Lauren Radford, Silvia S. Jurisson, Heather M. Hennkens, Fabio Gallazzi, Michael R. Lewis, Marina Kuchuk
Publikováno v:
Nuclear Medicine and Biology. :46-52
Introduction With the long-term goal of developing a diagnostic (99mTc) and therapeutic (186Re) agent pair for targeting somatostatin receptor (SSTR)-positive neuroendocrine tumors (NETs), we developed novel metal-cyclized peptides through direct lab
Autor:
Heather M. Hennkens, Rajendra P. Bandari, Antonio Shegani, Pavithra H.A. Kankanamalage, Marina Kuchuk, George Makris, Charles J. Smith
Publikováno v:
Bioconjugate Chemistry. 32:1290-1297
We report herein the preclinical evaluation of new [64Cu]Cu-gastrin-releasing peptide receptor (GRPR)-targeting tracers, employing the potent peptide antagonist DPhe-Gln-Trp-Ala-VaI-Gly-His-Sta-Leu-NH2 conjugated to NOTA (in 1) or NODAGA (in 2) chela
Autor:
Heather M. Hennkens, Rajendra P. Bandari, Silvia S. Jurisson, Marina Kuchuk, George Makris, Charles J. Smith
Publikováno v:
Molecular Imaging and Biology. 23:52-61
The goal of this work was to develop hydrophilic gastrin-releasing peptide receptor (GRPR)-targeting complexes of the general formula fac-[M(CO)3(L)]+ [M = natRe, 99mTc, 186Re; L: NOTA for 1, NODAGA for 2] conjugated to a powerful GRPR peptide antago
Autor:
Chrysovalantis Vergandis, George Makris, Ioanna Tsoumbou, George Liapis, Sophia Lionaki, Evangelos Mantios, Smaragdi Marinaki, Ioannis Boletis
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 3632, p 3632 (2021)
Journal of Clinical Medicine
Volume 10
Issue 16
Journal of Clinical Medicine
Volume 10
Issue 16
Purpose: Minimal change disease (MCD) is considered a relatively benign glomerulopathy, as it rarely progresses to end-stage kidney disease. The aim of this study was to describe the characteristics and outcomes of adults with MCD and identify potent
Autor:
Marina Kuchuk, Silvia S. Jurisson, Fabio Gallazzi, Heather M. Hennkens, Charles J. Smith, George Makris
Publikováno v:
Nuclear Medicine and Biology. 71:39-46
Introduction The aim of this work was to develop diagnostic (99mTc) and therapeutic (186Re) agents for targeting somatostatin receptor (SSTR)-positive neuroendocrine tumors (NETs). In this regard, we evaluated in vitro complexes of the general formul